• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

SUPPRESSION OF TUMOR GROWTH BY ANTIANGIOGENIC AGENT AND INDUCTION TO TUMOR DORMANCY IN BREAST CANCER

Research Project

Project/Area Number 12671139
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field General surgery
Research InstitutionGUNMA UNIVERSITY FACULTY OF MEDICINE

Principal Investigator

HORIGUCHI Jun (2001)  GUNMA UNIVERSITY FACULTY OF MEDICINE ASSISTANT PROFESSOR, 医学部, 助手 (70272242)

武井 寛幸 (2000)  群馬大学, 医学部, 助手 (40261846)

Co-Investigator(Kenkyū-buntansha) KURABAYASHI Masahiko  GUNMA UNIVERSITY FACULTY OF MEDICINE, PROFESSOR, 医学部, 教授 (00215047)
堀口 淳  群馬大学, 医学部, 助手 (70272242)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 2001: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 2000: ¥1,100,000 (Direct Cost: ¥1,100,000)
KeywordsANTIANGIOGENIC AGENT / TNP-470 / APOPTOSIS / MDA-MB-231 TUMOR / UFT / VEGF / TAMOXIFEN / DORMANCY THERAPY / 血管新生 / MDA-MB-231 / 乳癌 / Vascular endothelial growth factor / Apoptosis / 5-fluorouracil
Research Abstract

Angiogenesis is one of the key mechanisms of tumor development, invasion and metastasis. Suppression of tumor growth by antiangiogenic agent (TNP-470) is induced by apoptosis of cancer cells. Combination therapy of TNP-470 with UFT suppressed growth of MDA-MB-231 tumor compared to TNP-470 alone. The 5-FU concentration was higher in MDA-MB-231 tumors treated by TNP-470 plus UFT than TNP-470 alone. It was suggested that TNP-470 might increase 5-FU concentration in MDA-MB-231 tumors. Suppression of tumor growth by combination therapy of UFT with TNP-470 may be owing to the increase of 5-FU in the tumors. VEGF is one of growth factors with strong angiogenesis. VEGF production in cancer cells is suppressed by some chemo- and/or endocrine therapy. Tamoxifen inhibited VEGF production of ER-positive MCF-7 cells. Similarly, combination therapy of UFT with TNP-470 decreased VEGF concentration in MDA-MB-231 tumors. VEGF production was not suppressed by TNP-470 alone. Combination therapy of UFT with TNP-470 inhibited VEGF production of MDA-MB-231 tumors, which might be induced by increase of intra-tumoral concentration of 5-FU. Combination therapy of chemo-endocrine and antiangiogenic agents may induce breast cancer to tumor dormancy.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Horiguchi J, et al.: "Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancer"Br J Cancer. 86. 222-225 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Takei H, et al.: "In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer"Breast Cancer. 9. 39-42 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 堀口 淳, 他: "乳癌の臨床:基礎と臨床"メディカルビュー杜. 239 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Takei Y, et al.: "In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer"Breast Cancer. 9(1). 39-42 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Horiguchi J, et al.: "Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancer"Br J Cancer. 86. 222-225 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Horiguchi J., Takei H., Koibuchi Y., et al.: "Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancer"Br J Cancer. 86. 222-225 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Takei H., et al.: "In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer"Breast Cancer. 9. 39-42 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] 堀口 淳, 他: "乳癌の臨床 : 基礎と臨床"メディカルレビュー社. 239 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Takei H,Eun-Sook Lee,Angela Cisneros, et al: "Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice"Cancer Letters. 155. 129-135 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Takei H,Iino Y,Horiguchi J, et al: "Highest microvessel count as a long-term prognostic factor in Japanese breast cancer patients"Cancer Letters. 156. 109-116 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi